First Look Analysts Research Calls for Wednesday, March 8
This report was sent to Briefing.com subscribers earlier today. Upgrades: > AGNC Investment (AGNC) upgraded to Overweight from Neutral at JP Morgan; tgt $12.50 > Atlantica Yield (AY) upgraded to Buy from Neutral at BofA Securities; tgt $32 > CMS…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> AGNC Investment (AGNC) upgraded to Overweight from Neutral at JP Morgan; tgt $12.50
> Atlantica Yield (AY) upgraded to Buy from Neutral at BofA Securities; tgt $32
> CMS Energy (CMS) upgraded to Buy from Neutral at BofA Securities
Downgrades:
> Ares Commercial Real Estate (ACRE) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt $12.50
> Cara Therapeutics (CARA) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $6
Others:
> Axon (AXON) initiated with a Buy at Goldman; tgt $263
> Bowlero (BOWL) initiated with a Buy at Canaccord Genuity; tgt $22
> Lantheus Holdings (LNTH) initiated with a Mkt Outperform at JMP Securities; tgt $120
> Napco Security Systems (NSSC) initiated with an Outperform at William Blair
> Piedmont Lithium (PLL) initiated with an Outperform at Macquarie; tgt $140
> Sabre (SABR) initiated with an Underperform at Bernstein; tgt $4
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.
